about
Facile self-assembly of neutral dendritic metallocycles via oxygen-to-platinum coordination.Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug deliveryCoordination-driven self-assembly of M3L2 trigonal cages from preorganized metalloligands incorporating octahedral metal centers and fluorescent detection of nitroaromatics.Encapsulation of Pt(IV) Prodrugs within a Pt(II) Cage for Drug Delivery.Designed post-self-assembly structural and functional modifications of a truncated tetrahedron.Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug.A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-ChemotherapyMechanistic Studies of the Anticancer Activity of An Octahedral Hexanuclear Pt(II) Cage.Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy.Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents.Necroptosis-inducing rhenium(V) oxo complexes.Metallosupramolecular tetragonal prisms via multicomponent coordination-driven template-free self-assembly.A facile approach toward multicomponent supramolecular structures: selective self-assembly via charge separation.Self-selection in the self-assembly of isomeric supramolecular squares from unsymmetrical bis(4-pyridyl)acetylene ligands.Construction of functionalized metallosupramolecular tetragonal prisms via multicomponent coordination-driven self-assembly.Post-self-assembly covalent chemistry of discrete multicomponent metallosupramolecular hexagonal prisms.Self-Assembly of Coordinative Supramolecular Polygons with Open Binding Sites.Construction of endo-functionalized two dimensional metallacycles via coordination-driven self-assemblyA breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complexConstruction of hexagonal prisms of variable size via coordination-driven multicomponent self-assembly.Multicomponent supramolecular systems: self-organization in coordination-driven self-assembly.A highly efficient approach to the self-assembly of hexagonal cavity-cored tris[2]pseudorotaxanes from several components via multiple noncovalent interactions.Coordination-driven self-assembly of truncated tetrahedra capable of encapsulating 1,3,5-triphenylbenzene.Coordination-driven self-assembly of three-dimensional supramolecular dendrimers.Direct and quantitative characterization of dynamic ligand exchange between coordination-driven self-assembled supramolecular polygons.Synthesis of six-component metallodendrimers via [3 + 3] coordination-driven self-assembly.Coordination-driven self-assembly of cavity-cored multiple crown ether derivatives and poly[2]pseudorotaxanes.Size selective self-sorting in coordination-driven self-assembly of finite ensembles.Correction to "A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy"A spermine-conjugated lipophilic Pt(iv) prodrug designed to eliminate cancer stem cells in ovarian cancerDual-action organoplatinum polymeric nanoparticles overcoming drug resistance in ovarian cancerMonofunctional platinum(ii) anticancer complexes based on multidentate phenanthridine-containing ligand frameworksEngineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood
P50
Q33494897-27626204-48F5-40AC-9E65-C5EC4DCA94EEQ33825880-65A0A514-CEC3-4572-8761-7A0F4AE5DFDFQ34766169-E821AD58-A25F-40AF-A3C1-30DAAE14A940Q35000093-48D8931E-A95B-4C76-A5BF-0508C438D7A0Q35540456-A7699554-E6C5-4320-8618-EC354D1B06D2Q36459188-3541ACBF-3DFB-4D97-BEB6-435CDF2BB6BBQ36635458-06B89B9E-E8F5-4A6D-BFE1-0721F4EC4D7BQ37392185-D324E79F-5CB5-4A69-AC6C-D7728781692DQ37500884-BDEA4061-3531-4672-9D20-C460760A9C83Q38717698-BC4D02C9-7E96-40BF-86E4-0486406BA13AQ38907938-BA97A2E0-D442-428D-88A7-D3782AF21D82Q40616634-C72F21A6-5124-4ADF-923F-1992D0C99CB6Q41667857-E7D16312-3765-477A-AEFD-94709091AF80Q41838391-B45B9F6F-EC71-4574-A0A9-CCD863CEE7B9Q41848121-93498CE9-C502-4900-9CC5-B7E58E5D30CDQ41865004-32F278B3-9A24-4790-AB6F-348E15A8B80EQ41912042-65DE6849-1C6E-4DCB-95F6-EFE1C5E85000Q41943909-C60D3698-E58C-48EF-A144-78FD88D31134Q42113076-9BDF87D4-2863-4D2D-AC0F-C564C3E87F1FQ42135296-0D456BDF-FFE7-44CB-ADF3-6A8420845920Q42148272-91D82F55-E63B-4C9C-AEE1-4D76943FE453Q42282673-ABFE3B66-950C-4AE3-8E9F-DEF0160536BBQ42377069-943CAFD7-CB59-40C4-9971-80955244244FQ42739598-2A5137B3-33D6-4BB4-A42A-9E6BE5265CF2Q43030306-5910F3A1-9684-48D2-BCC5-E2750724368DQ43138751-6ED1AE70-9B27-4ABB-9879-1EF99739ABF5Q46701907-0664084B-771C-4846-A9AA-C9EA4E52D70CQ47236479-4A3A2C97-423B-43ED-A41C-A058D0E579F5Q87371880-B56EBBF8-AA5D-45BF-BAE6-4133F5F5897CQ91875953-29BAA786-BB39-4EFC-B41D-1B2444DE7310Q92231089-E46D0682-0A0C-47F0-B6F8-1FE7169AE487Q93273640-C625CC6C-FC4F-457C-9257-DE7495A6CAEFQ96112159-C999982B-BDCB-4794-B35D-34E5940B20A9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yao-Rong Zheng
@ast
Yao-Rong Zheng
@en
Yao-Rong Zheng
@es
Yao-Rong Zheng
@nl
Yao-Rong Zheng
@sl
type
label
Yao-Rong Zheng
@ast
Yao-Rong Zheng
@en
Yao-Rong Zheng
@es
Yao-Rong Zheng
@nl
Yao-Rong Zheng
@sl
altLabel
Yao-Rong Zheng
@en
prefLabel
Yao-Rong Zheng
@ast
Yao-Rong Zheng
@en
Yao-Rong Zheng
@es
Yao-Rong Zheng
@nl
Yao-Rong Zheng
@sl
P106
P1153
23013497800
P31
P496
0000-0003-4605-1121